Biosig Technologies Inc (BSGM) Financials

$5.01

$4.52 (913.55%)

As on 10-Oct-2025 09:30EDT

Market cap

$215 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

36.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.01	0.04	0.02	0.29	0.44	0.12
Cost of Revenue	--	--	0.36	0.06	0.20	0.55
Gross Profit	--	--	-0.34	0.23	0.24	-0.55
Operating Expenses	27.50	12.65	28.53	27.49	33.65	59.18
Operating Profit (EBIT)	-27.48	-12.61	-28.51	-27.27	-33.41	-59.18
Other Income	--	--	--	--	--	0.00
Profit before Tax	-26.18	-10.34	-28.69	-27.26	-32.86	-59.14
Provision for Tax	--	--	0.36	0.01	-1.49	-6.97
Profit after Tax (Net Income)	-26.20	-10.33	-29.04	-27.27	-31.36	-52.17
Minority Interest	-0.02	0.01	-0.35	0.21	0.94	0.80
Consolidated Profit	--	--	--	--	-31.93	-52.23

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-3.51	-1.44	-2.91	0.42	12.35	24.48
Minority Interest	-0.02	--	--	--	--	0.80
Non-Current Liabilities	--	--	0.10	0.45	0.38	0.00
Current Liabilities	113.20	2.26	4.58	3.26	2.58	5.11
Total Liabilities	113.20	0.84	1.80	4.11	15.52	30.39

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	106.72	0.50	1.27	2.98	1.63	1.05
Current Assets	3.00	0.34	0.53	1.13	13.89	29.34
Total Assets	222.92	--	1.80	4.11	15.52	30.39
Total Debt*	--	--	0.45	0.77	0.66	0.31
Net Current Assets	-110.20	-1.92	-4.05	-2.13	11.32	24.23

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-4.76	-17.31	-21.71	-26.40	-26.60
Cash Flow from Investing Activities	--	--	--	--	-0.54	-0.09
Cash from Financing Activities	--	4.71	17.33	10.57	10.33	42.85
Net Cash Inflow / Outflow	--	--	--	--	--	16.16

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	--	--	-3.21	-5.31	-8.86	-16.87
Cash EPS ($)	--	--	-3.17	-5.25	-8.80	-16.69
Adjusted Book Value ($)	--	--	--	0.08	3.49	7.91
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	-1.92	-4.23	-7.46	-8.60
Free Cash Flow per Share ($)	--	--	-1.94	-4.26	-7.61	-8.63

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	529.74	4,544.76	-384.50	-165.98	-282.99
ROE (%)	--	474.72	2,327.94	-427.31	-170.35	-291.18
ROA (%)	-22.88	-782.58	-983.11	-277.86	-136.64	-233.95
EBIT Margin (%)	-211,400.00	-31,522.50	-158,400.00	-9,533.22	-7,576.19	-50,155.93
Net Margin (%)	-201,515.38	-25,825.00	-161,338.89	-9,535.31	-7,111.56	-44,593.16
Cash Profit Margin (%)	-0.32	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-65.79	1.22	-0.94	-0.35	2.74	--
EBIT Growth (%)	-26.79	55.78	-4.57	18.40	43.55	-71.03
Net Profit Growth (%)	-24.76	64.43	-6.49	13.04	39.89	-53.81
EPS Growth (%)	--	--	0.40	0.40	0.47	-0.11
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	--	-0.15	-0.08	-0.25	-0.23
Price / Book Value	36.58	--	-1.47	5.16	0.64	0.49
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.34	--	-0.16	-0.09	0.09	0.27
Close Price ($)	--	--	4.75	4.20	22.30	39.00
High Price ($)	--	--	16.50	24.60	61.40	124.30
Low Price ($)	--	--	2.55	2.51	21.10	23.60
Market Cap ($ Cr)	215.15	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	--	-0.16	1.83	0.05	0.01
Short term debt to equity ratio	--	--	-0.12	0.75	0.02	0.01
Current Ratio	0.03	0.15	0.12	0.35	5.39	5.74
Quick Ratio	0.03	--	0.14	0.24	4.66	5.59
Interest Coverage	--	--	--	-9,088.33	-16,705.50	-1,315.20

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	272.50	133.33	3.15	0.00	0.00
Asset Turnover	0.00	0.03	0.01	0.03	0.02	0.01
Receivable days	--	607.23	334.81	5.75	0.00	0.00
Inventory Days	--	--	117.87	7,103.15	2,431.02	446.83
Payable days	--	--	2.89	12.34	28.45	124.92
Cash Conversion Cycle	--	--	449.80	7,096.56	2,402.57	321.92

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.